ReviewCureus2025
Advances in Infection Prevention for Pediatric and Neonatal Populations: Classification of Methods and the Emerging Superiority of Ultraviolet-C (UV-C) Technologies.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare-associated infections (HAIs) continue to pose major risks to pediatric and neonatal patients, whose immature immune systems and unique vulnerabilities demand tailored infection prevention strategies. Traditional methods, including chemical disinfectants, procedural protocols, and physical hygiene measures, have contributed to reductions in HAIs but remain limited by human error, environmental toxicity, and the rise of antimicrobial resistance. Advances in disinfection technologies, particularly ultraviolet-C (UV-C) systems, offer promising new avenues for safer, more effective pathogen control. This review systematically classifies infection prevention methods into chemical, physical, procedural, and emerging technology categories, emphasizing their respective strengths and limitations. Special attention is given to UVCeed (UVCeed Inc., Effingham, Illinois, United States), a next-generation UV-C disinfection device that delivers rapid, targeted, and chemical-free decontamination with minimal reliance on human compliance. UVCeed's integration into pediatric infection control protocols represents a major advance, addressing critical gaps left by conventional methods. By synthesizing current knowledge and highlighting future directions, this article aims to guide clinicians, infection control specialists, and healthcare administrators toward more comprehensive, technology-enhanced approaches to safeguarding pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.